WhichRecall
Class IIReported 2025-11-05

Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-049-88.

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC

Reason for Recall

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.

Advertisement
Recall Number
D-0147-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-10-28
Reported
2025-11-05
Distribution
U.S Nationwide.
Code Info
Lot #: AD48709, Expiry: 4/30/2026; AD50894, Expiry: 5/31/2026.
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement